Is Unihealth Hosp overvalued or undervalued?

As of 18 November 2025, the valuation grade for Unihealth Hospital has moved from very attractive to attractive. The company is currently considered fairly valued. Key ratios include a PE ratio of 24.13, an EV to EBITDA of 9.53, and a PEG ratio of 0.65, indicating a relatively strong growth potential compared to its price.
In comparison to its peers, Unihealth's PE ratio is significantly lower than that of Max Healthcare, which is at 77.03, and Narayana Hrudaya, at 46.82, both categorized as expensive. Apollo Hospitals, also attractive, has a PE of 63.51, further highlighting Unihealth's favorable valuation. Notably, Unihealth has outperformed the Sensex with a year-to-date return of 50.61% compared to the Sensex's 9.58%, reinforcing its attractive position in the market.